ClinicalTrials.Veeva

Menu

Tunisian Lung Cancer Study (LUNG-TUN)

D

DACIMA

Status

Begins enrollment this month

Conditions

Pulmonary Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT06934499
DAC-01-LUNGTUN

Details and patient eligibility

About

This is a prospective, multicenter, observational, national study. Eligible patients will be recruited consecutively among subjects with proven lung cancer, including any disease stage withclinical, therapeutic and evolutive discription.

Enrollment

1,334 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age more than 18 years
  • Patients receiving health care in the departments of pulmonology, oncology, radiation oncology and thoracic surgery, whose diagnosis is confirmed histologically and/or by cytology, at least 3 months before the inclusion date
  • Informed consent

Exclusion criteria

  • None

Trial contacts and locations

1

Loading...

Central trial contact

Soraya Fenniche, MD; Nesrine Mejri, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems